Reimbursement issues, the need for quality control and impact on workflows were other factors identified in a European study affecting the adoption of apoint of care c-reactive protein test in primary care clinics to limit antibioticuse in lower respiratory infections. The gene discussed is CRP; the disease is respiratory tract infectious disorder.